Introduction: The Emergence of Psychedelic Therapy Across Europe Psychedelic therapy has rapidly evolved in Europe as a legitimate, research-driven approach to treating addiction, mood disorders, and cognitive impairments. Substances such as Ibogaine, psilocybin, and mescaline are increasingly integrated into structured clinical programs designed to address complex mental health challenges, including ADHD, depression, and sleep disorders. […]